Health properties o/Spirulina spp..;Propriedades de saúde de Spirulina Spp

Revista de Ciencias Farmaceuticas Basica e Aplicada

Volumn 29, Issue 2, 2008, Pages 109-117

  Ambrosi, M A ^a   Reinehr, C O ^a   Bertolin, T E ^a   Costa, J A V ^b   Colla, L M ^a,c  

^a UNIVERSITY OF PASSO FUNDO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE   (Brazil)

^c Curso de Engenharia de Alimentos   (Brazil)

Author keywords

Cancer; Diabetes; Hyperlipi demia; Malnutrition; Nutraceutical; Spirulina spp.

Indexed keywords

ANTIRETROVIRUS AGENT; BACTERIAL ANTIGEN; CISPLATIN; GENTAMICIN; GLUCOSE; HEAVY METAL; LIPID; MINERAL; NUTRACEUTICAL; PARACETAMOL; PROBIOTIC AGENT;

ANTIVIRAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BLOOD PRESSURE; CANCER THERAPY; CHEMICAL COMPOSITION; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CYTOSTASIS; CYTOTOXICITY; DIABETES MELLITUS; DIET SUPPLEMENTATION; DRUG POTENCY; FOOD; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; HYPERTENSION; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INTESTINE FLORA; LACTOBACILLUS; LIPID BLOOD LEVEL; MALNUTRITION; NEPHROTOXICITY; NONHUMAN; NUTRITION; OBESITY; RADIATION PROTECTION; RENAL PROTECTION; SPIRULINA; STOMACH ABSORPTION; VIRUS INHIBITION; VIRUS REPLICATION; WEIGHT REDUCTION;

EID: 67049134334     PISSN: 18084532     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Alonso DL, Maroto FG. Plants as 'chemical factories' for the production of polyunsaturated fatty acids. Biotechnol Adv. 2000; 18:481-97.
2. Andlauer W, Fiirst P. Nutraceuticals: a piece of history, present status and outlook. Food Res Lit 2002; 35:171-6.
3. Ayehunie S, Belay A, Baba TW, Ruprecht RM. Inhibition of HIV-1 replication by an aqueous extract of Spirulina platensis. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18(1):7-12.
4. Becker EW, Jakober B, Luft D, Schmilling RW. Clinical and biochemical evaluations of Spirulina with regard to its application in the treatment of obesity. Nutr Rep hit 1986; 33(4):565.
5. Belay A, Ota Y, MiyakawaK, Shimamatsu H. Current knowledge on potential health benefits of Spirulina. JAppl Phycol 1993; 5:235-41.
6. Brasil. Agenda Nacional de Vigilancia Sanitaria. VII Lis- ta dos novos ingredientes aprovados-Comissoes Tecno- cientificas de Assessoramento em Alimentos Funcionais e Novos Alimentos. Disponivel em URL: http://www.anvisa. gov.br/alimentos/comissoes/novos-ingredientes.htm. [08 mai2008].
7. BruntonLL, Lazo JS, Parker KL, editors. Goodman & Gil- man: as bases farmacologicas da terapeutica. ll.ed. Rio de Janeiro: McGraw Hill; 2006. 1821p.
8. nd.ed. New York: Springer-Velag, 2001. v. 1, p.557-9
9. Cecil RL, Goldman L, Ausiello D, editores. Cecil: tratado de medicina interna. 22.ed. Rio de Janeiro: Elsevier, 2005a v.l.
10. Cecil RL, Goldman L, Ausiello D, editores. Cecil: tratado de medicina interna. 22.ed. Rio de Janeiro: Elsevier; 2005b. v.2.
11. Colla LM, Bertolin TE, Costa JY Fatty acids profile of Spirulina platensis grown under different temperatures and nitrogen concentrations. ZNaturforsch 2004; 59c:55-9.
12. Colla LM, Furlong EB, Costa, JAV. Antioxidant Properties of Spirulina (Arthospira) platensis Cultivated Under Different Temperatures and Nitrogen Regimes. Braz Arch Biol Technol 2007a; 50(l):161-7.
13. Colla LM, Reinehr CO, Reichert C, Costa JAV. Production of biomass and nutraceutical compounds by Spirulina platensis under different temperature and nitrogen regimes. Bioresour Technol.2007b; 98:1489-93.
14. Colla LM, Muccillo-Baisch AL, Costa JV. Spirulina platensis effects on the levels of total cholesterol, HDL and triacylglycerols in rabbits fed with a hypercholesterolemic diet. BrazArch Biol Technol 2008; 51(2):405-11.
15. Dainippon Ink & Chemicals, Tokyo Kenkyukai, inventors and assignee. Antitumoral agents containing phycobilin-also used to treat ulcers and hemorrhoidal bleeding. JP patent 58065216 A 830418. 1983 April 18. 6p.
16. Damaso A. Obesidade. Rio de Janeiro: Guanabara Koogan S.A., 2003. 590p.
17. Damaso AR, Nascimento CMO. Efeitos do exercicio reali- zado durante o ciclo reprodutivo sobre o metabolismo lipi- dico: analise de estudos utilizando animais experimentais. Rev Paul Ed Fis 1998; 12(l):54-70.
18. De Caire GZ, de Cano MS, de Mule CZ, Steyerthal N, Pi- antanida M. Effect of Spirulina platensis on glucose, uric acid and cholesterol levels in the blood of rodents. IntJExp Bot 1995; 57:93-6.
19. Devi MA, Venkataraman LV. Hypocholestemic effect of blue-green algae Spirulina platensis in albino rats. Nittr RepM\9?3; 28:519-30.
20. DRI. Dietary Reference Intake. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carote- noids. Institute of Medicine (IOM), 2000. Disponivel em URL: http://books.nap.edu/openbook.php7record- id=9810&page=509. [24 mar 2008]
21. Estrada JE, Bescos P, Villar Del Fresno AM. Antioxidant activity of different fractions of Spirulina platensis protean extract. IlFarmaco 2001; 56:497-500.
22. Fukino H, Takagi Y, Yamane Y. Effect of Spirulina on the renal toxicity induced by inorganic mercury and cisplatin. Eisei Kagaku 1990; 36:5.
23. Harrison TR, Kasper DL, editores. Harrison: medicina interna. 16.ed. Rio de Janeiro: McGraw Hill; 2006. v.l.
24. Hayashi K, Hayashi T, Kojima I. A natural sulfated polysaccharide, Calcium Spirulan, isolated from Spirulina platensis: in vitro and ex vivo evaluation of anti-Herpes simplex virus and anti-human immunodeficiency virus activities. AIDS Res Human Retroviruses 1996a; 12:1463-71.
25. Hayashi T, Hayashi K, Maeda M, Kojima I. Calcium Spirulan, an inhibitor of enveloped virus replication, from a blue-green alga Spirulina platensis. J Nat Prod 1996b; 59(l):83-7.
26. Henrikson, R. Microalga Spirulina: superalimento del future Barcelona: Ediciones Urano S.A., 1995.
27. Hosoyamada Y, Takai T, Kato T. Effects of water-soluble and insoluble fractions of Spirulina on serum lipid components and glucose tolerance in rats. JJpn Soc Nutr Food Sci 1991; 44:273-7.
28. Hungenholtz J, Smid EJ. Nutraceutical production with food-grade microorganisms. Curr Opin Biotechnol 2002; 13:497-507.
29. Iwata K, Inayama T, Kato, T. Effects of Spirulina platensis on plasma lipoprotein lipase activity in fructose induced hiperhpidemic rats. J Nutr Sci Vitaminol 1990; 36:165-71.
30. Karam LM, Soccol CR. Efeito da temperatura e pH no culti- vo de Spirulina major. Arq Cien Vet loot 2007; 10(l):5-7.
31. Kato T, Takemoto K, Katayama H, Kuwabara Y. Effects of Spirulina platensis on dietary hypercholesterolemia in rats. JJpn Soc Nutr Food Sci 1984; 37:323-32.
32. Kwak N, Jukes DJ. Functional foods. Part 1: the development of a regulatory concept. Food Control 2001; 12:99-107.
33. Lang V, Bellisle F, Oppert JM, Craplet C, Bornet FRJ, Slama G. Satiating effect of proteins in healthy subjects: a comparison of egg albumin, casein, gelatin, soy protein, pea protein, and wheat gluten. Am J Clin Nutr 1998; 67:197.
34. Loseva LP, Dardynskaya IV. Spirulina: a natural sorbent of radionucleides. Research Institute of Radiation Medi-cine, Minsk, Belarus. 6"'.International Congress of Applied Algology, Sep 1993; Czech Republic, Belarus, 1993. Dis- ponivel em URL: http://www.spirdinasource.com/ Hbrary- human.html. [04 jul 2008]
35. Mani S, Iyer U, Subramanian S. Studies on the effect of Spirulina supplementation in control of diabetes mellitus. In: Subramanian G et al., eds. Cyanobacterial biotechnology. Enfield, USA: Science Publishers Inc; 1998. p.301-4.
36. Mathew B, Sankaranarayanan R, NairPP, Varghese C, So- manathan T, Amma BP, Amma NS, Nair MK. Evaluation of chemoprevention of oral cancer with Spirulina fusiformis. Nutr Cancer 1995; 24(2): 197-202.
37. Miranda MS, Cintra RG, Barros SBM, Mancini-Filho J. Antioxidant activity of the microalga Spirulina maxima. BrazJMedBiolRes 1998; 31:1075-9.
38. Moraes F, Colla LM. Alimentos funcionais e nutraceuticos: definigoes, legislagao e beneficios a saiide. Rev Eletron Farm 2006; 3(2): 109-22.
39. Moriel P, Rodrigues D, Abdalla DSP, Bertolami MC, Andra- de PM. Antioxidantes e oxidabilidade da LDL em pacientes hiperlipidemicos. Rev Bras Anal Clin 1998; 30(4):176-80.
40. Nayaka N, Homma Y, Goto Y. Cholesterol lowering effect of Spirulina. Nutr Rep Int 1988; 37:1329-7.
41. NelsonDL. Lehninger: principios de bioquimica. 3.ed. Sao Paulo: Sarvier, 2002. 975p.
42. Nunes MAA, Appolinario JC, Abuchaim ALG, Coutinlio W, eds. Transtornos alimentares e obesidade. Porto Alegre: Artmed; 1998. 215p.
43. Paiva AC, Alfenas RCG, Bressan J. Efeitos da alta inges- tao diaria de proteinas no metabolismo. Rev Bras Nutr Clin 2007; 22(l):83-8.
44. Parades-Carbajal MC, Torres-Duran PV, Diaz-Zagoya JC, Mascher D, Juarez-Oropeza MA. Effects of dietary Spirulina maxima on endothelium dependent vasomotor responses of rat aortic rings. Life Sci 1997; 61:211-9.
45. Parikh P, Mani U, Iyer U. Role of Spirulina in the control of glycemia and lipidemia in type 2 diabetes mellitus. J Med Food 2001; 4:193-9.
46. Pelczar MJ, Chan ECS, Krieg NR. Microbiologia: conceitos e aplicagoes. 2.ed. Sao Paulo: Makron Books; 2005. v. 2.
47. Perez LV, Abraham CM, Leyva IT, Ferrer BBS, Suarez VM, Segura MS. Efecto in vitro de la Spirulina sobre la respuesta inmune. Re\> Cubana Hematol Inmunol Hemo- ter 2002; 18(2). [periodico on-line] Disponivel em URL: http://bvs.sld.cu/revistas/hili/voll8-2-02/Mh06202.htm [10 mar 2008].
48. Qishen P, Baojiang G, Kolman A. Radioprotective effect of extract from Spirulina platensis in mouse bone marrow cells studied by using the micronucleus test. Toxicol Lett 1989; 48(2): 165-9.
49. Richmond A. Handbook of microalgal mass culture. Boston: CRC Press; 1990.
50. Roberfroid M. Functional food concept and its application to prebiotics. Dig Liver Dis 2002; 34(2): 105-10.
51. Schwartz J, Shklar G, Reid S, And Trickier D. Prevention of experimental oral cancer by extracts of Spirulina-Du- naliella algae. Nutr Cancer 1988; 11:127-34.
52. Schwartz J, Shklar G, Suda D. Inhibition of experimental oral carcinogenesis by topical beta carotene. Carcinogenesis 1986; 7(5):711-5.
53. Seshadri CV. Large-scale nutritional supplementation with Spirulina alga. All India Coordinated Project on Spirulina. Shri Aim Murugappa Chettiar Research Center (MCRC). Madras, India, 1993.
54. Sharon J. Imunologia bdsica. Rio de Janeiro: Guanabara Koogan; 2000. 267p.
55. Simpore J, Kabore F, Zongo F, Dansou D, Bere A, Pigna- telli S, Biondi DM, Ruberto G, Musumeci S. Nutrition rehabilitation of undernourished children utilizing Spiruline and Misola. Nutr J 2006; 5:3.
56. Souza FT, Margarites AC, Colla LM, Costa JAV, Bertolin TE. Avalia?ao do potencial antioxidante da ficocianina em sistema lipidico oleo de soja e azeite de oliva. Alim Nutr 2006; 17(3):287-91.
57. Torres-Duran PV, Ferreira-Hermosillo A, Juarez-Oropeza MA. Antihyperlipemic and antihypertensive effects of Spirulina maxima in an open sample of Mexican population: a preliminary report. Lipids Health Dis 2007; 6:33.
58. lh.ed. San Francisco: Pearson Benjamin Cummings; 2007. The prokary- otes: domains bacteria and archae; 328-9
59. Tsuchihashi N, Watanabe T, Takai Y. Effect of Spirulina platensis on caecum content in rats. Bull Chiba Hyg Coll 1987; 5(2):27-30.
60. Von Der Weid D, Dillon JC, Falquet J. Malnutrition: a silent massacre. Geneve: Antenna Technology; 2000.13p.
61. Vonshak A. Spirulina platensis (Arthrospira): physiology, cell-biology and biotechnology. London: Taylor & Francis; 1997.
62. Yamane Y. The effect of Spirulina on nephrotoxicity in rats. In: Annual Symposium of the Pharmaceutical Society of Japan; 1988 Apr 15; Chiba University, Japan. 1988. Dis- ponivel em URL: http://www.spimlimsource.com/ library- kidney.html [04 jul 2008].
63. Yonghuang W. The study on curative effect of zinc containing Spirulina for zinc deficient childrea Capital Medical College, Beijing. In: 5° International Phycological Congress; June 1994; Qingdao, China, 1994. Disponivel em URL: http://wmv.spirulinasource.com/library-malnutri- tioahtml [04 jul 2008].